Trial Information
The Efficacy of Neurofeedback to Improve Processing Speed, Attention and Memory in Childhood Brain Tumour Survivors: a Randomized Controlled Trial
Inclusion Criteria:
- Being treated for a brain tumour before the age of 16 years
- Age between 8-18 years at time of enrolment
- Off treatment at least two years
- Problems on attention, or memory or speed processing as reported by parents in
screening test
- Being able to speak and understand the Dutch language
Exclusion Criteria:
- Premorbid AD/HD
- Mental or physical condition that make the neuropsychological assessment impossible
to finish
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
Neurocognitive functioning
Outcome Time Frame:
Before (T0) and after (T1) NFB training and 6 months follow up (T2)
Safety Issue:
No
Authority:
Netherlands: Medical Ethics Review Committee (METC)
Study ID:
UVA 2008-4013
NCT ID:
NCT00961922
Start Date:
January 2010
Completion Date:
July 2014
Related Keywords:
- Brain Tumors
- childhood brain tumour survivors
- Brain Neoplasms